FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

Prenatal exposure to air pollution ups child's autism risk Dec 19, 2:02 pm
Washington, Dec 19 (ANI): A new study has revealed that women who are exposed to high levels of fine particulate matter specifically during pregnancy-particularly during the third trimester-may face up to twice the risk of having a child with autism than mothers living in areas with low particulate matter.
Full Story
Fetal Echo: A window to the unborn heart Dec 18, 12:28 pm
Kochi, Dec. 18 (ANI): One in every 120 children in India are born with a heart defect and about a third of them have serious defects.
Full Story
Keeping fit does help avoid developing hypertension Dec 18, 12:28 pm
Washington, Dec 18 (ANI): People who keep fit face lesser chance of developing hypertension, says a new research.
Full Story
Christmas 'mistletoe' can also kiss away obesity-related liver disease Dec 18, 11:44 am
Washington, Dec 18 (ANI): Scientists have found that Mistletoe not only represents a kiss at Christmas time, but it may also help fight obesity-related liver disease.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY